Montelin, Myca .

HRN: 24-08-13  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
CEFUROXIME 750MG (VIAL)
11/12/2023
11/19/2023
IV
240mg
Q8H
Benign Febrile Seizure; PCAP B
Checking Final Appropriateness 
11/14/2023
CEFTRIAXONE 1G (VIAL)
11/14/2023
11/20/2023
IV DRIP
750mg
Q24h
BFC, PCAP
Checking Final Appropriateness 
11/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/22/2023
11/29/2023
IVT
110mg
Q24
Sepsis/PCAP
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: